CLINICAL QUESTION
Is there a reduction in mortality in patients with severe pneumonia or acute respiratory distress syndrome (ARDS) who receive adjunct corticosteroids?
BOTTOM LINE
Moderate-certainty evidence showed a reduction in short-term mortality in patients with severe pneumonia or ARDS who received adjunct corticosteroids. (Level of Evidence = 1a−)
SYNOPSIS
The investigators searched multiple databases, including MEDLINE, EMBASE, the Cochrane Library, and Google Scholar for randomized controlled trials that evaluated the effect of adjunct, low-dose, short-course systemic corticosteroids compared with standard care or placebo for the treatment of adult patients hospitalized with non–COVID-19 severe pneumonia or ARDS. Two reviewers independently selected studies, extracted data, and performed a risk-of-bias assessment. Twenty studies met the inclusion criteria: 15 studies enrolled patients with severe pneumonia (n = 2,445) and five enrolled patients with ARDS (n = 1,014). Most studies used hydrocortisone for 7 days. Overall, five of the severe pneumonia studies and one of the ARDS studies were at high risk of bias. Systemic corticosteroids reduced short-term mortality (death within 90 days) with moderate certainty in the severe pneumonia group (relative risk [RR] = 0.73; 95% CI, 0.57–0.93; I2 = 14%) and in the ARDS group (RR = 0.77; 95% CI, 0.61–0.99; I2 = 23%). The mortality benefit appeared to be regardless of dose and type of corticosteroid used. Low-certainty evidence showed that corticosteroids decreased the incidence of secondary shock in patients with severe pneumonia (RR = 0.49; 95% CI, 0.26–0.92; I2 = 55%). Neither group had an increase in hospital-acquired infections.
Study Design: Meta-analysis (randomized controlled trials)
Funding Source: Self-funded or unfunded
Setting: Inpatient (intensive care unit only)
Reference: Schildroth S, Gaston SA, Harmon QE, et al. A prospective study of hair dyes and uterine leiomyomata incidence in the study of environment, lifestyle, and fibroids. Fertil Steril. 2026;125(1):94-105.
Read the full article
Get immediate access, anytime, anywhere.
Choose a single article, issue, or full-access subscription.
Earn up to 14 CME credits per issue.
